✦ LIBER ✦

Clinical Outcomes in Kidney Transplant Recipients Receiving Long-Term Therapy With Inhibitors of the Mammalian Target of Rapamycin

✍ Scribed by F. Cortazar; M. Z. Molnar; T. Isakova; M. E. Czira; C. P. Kovesdy; D. Roth; I. Mucsi; M. Wolf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular Risk in Kidney Transplant

✍ E. Watorek; M. Szymczak; M. Boratynska; D. Patrzalek; M. Klinger 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Mammalian Target of Rapamycin Inhibitor

✍ B. L. Kasiske; A. de Mattos; S. M. Flechner; L. Gallon; H.-U. Meier-Kriesche; M. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 475 KB

Intestinal Kaposi sarcoma in a lung tran

✍ Lund, May Brit; Paulsen, Vemund; Aukrust, Pål 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Pneumonitis Associated With Mammalian Ta

✍ P. Errasti; D. Izquierdo; P. Martín; M. Errasti; F. Slon; A. Romero; F.J. Lavill 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Low-Dose Calcineurin Inhibitor Regimen C

✍ S. Kacar; A. Gurkan; C. Karaca; C. Varılsuha; S. Tilif 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Antitumor Efficacy of Mammalian Target o

✍ Álamo, J.M.; Bernal, C.; Marín, L.M.; Suárez, G.; Serrano, J.; Barrera, L.; Sous 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 125 KB